Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
3,498,975
-
Share change
-
+4,319
-
Total reported value
-
$358,000
-
Price per share
-
$0.10
-
Number of holders
-
29
-
Value change
-
-$138,524
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) as of Q2 2022
As of 30 Jun 2022,
SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,498,975 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., Linden Advisors LP, K.J. Harrison & Partners Inc, ARISTEIA CAPITAL LLC, Periscope Capital Inc., Castle Creek Arbitrage, LLC, Kepos Capital LP, SECURITY BENEFIT LIFE INSURANCE CO /KS/, Ibex Investors LLC, and Spartan Fund Management Inc..
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.